share_log

Tarsus Pharmaceuticals | 8-K: Tarsus Reports Strong Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Achievements

SEC announcement ·  Feb 27 13:49
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more